A Current Management Strategy for Children with Chronic Viral Hepatitis B, Based on International and National Guidelines

1. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Accountability for the global health sector strategies 2016–2021: actions for impact. World Health Organization. Geneva: World Health Organization, 2021; 108 p. ISBN 978-92-4-002708-4 (print version) ISBN 978-92-4-002707-7 (electronic version). Available from: https://www.who.int/publications/i/item/9789240027077 Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021 Accountability for the global health sector strategies 2016–2021: actions for impact World Health Organization Geneva World Health Organization 2021 108 p. ISBN 978-92-4-002708-4 (print version) ISBN 978-92-4-002707-7 (electronic version). Available from: https://www.who.int/publications/i/item/9789240027077 Search in Google Scholar

2. Global health sector strategy on viral hepatitis 2016–2021: Towards ending viral hepatitis. World Health Organization. Geneva: World Health Organization, 2016; 53 p. WHO reference number: WHO/HIV/2016.06. Available from: https://www.who.int/publications/i/item/WHO-HIV-2016.06 Global health sector strategy on viral hepatitis 2016–2021: Towards ending viral hepatitis World Health Organization Geneva World Health Organization 2016 53 p. WHO reference number: WHO/HIV/2016.06. Available from: https://www.who.int/publications/i/item/WHO-HIV-2016.06 Search in Google Scholar

3. Progress report on HIV, viral hepatitis and sexually transmitted infections 2019: accountability for the global health sector strategies, 2016–2021. World Health Organization. Geneva : World Health Organization, 2019; 39 p. WHO Document number: WHO/CDS/HIV/19.7. Available from: https://apps.who.int/iris/handle/10665/324797 Progress report on HIV, viral hepatitis and sexually transmitted infections 2019: accountability for the global health sector strategies, 2016–2021 World Health Organization Geneva World Health Organization 2019 39 p. WHO Document number: WHO/CDS/HIV/19.7. Available from: https://apps.who.int/iris/handle/10665/324797 Search in Google Scholar

4. Combating hepatitis B and C to reach elimination by 2030: advocacy brief. World Health Organization. Geneva: World Health Organization, 2016; 17 p. WHO document number: WHO/HIV/2016.04. Available from: https://apps.who.int/iris/handle/10665/206453 Combating hepatitis B and C to reach elimination by 2030: advocacy brief World Health Organization Geneva World Health Organization 2016 17 p. WHO document number: WHO/HIV/2016.04. Available from: https://apps.who.int/iris/handle/10665/206453 Search in Google Scholar

5. Cox AL, El-Sayed MH, Kao JH, Lazarus JV, Lemoine M, Lok AS, et al. Progress towards elimination goals for viral hepatitis. Nat Rev Gastroenterol Hepatol. 2020;17(9):533–42. doi: 10.1038/s41575-020-0332-6 CoxAL El-SayedMH KaoJH LazarusJV LemoineM LokAS Progress towards elimination goals for viral hepatitis Nat Rev Gastroenterol Hepatol. 2020 17 9 533 42 10.1038/s41575-020-0332-6 Open DOISearch in Google Scholar

6. Thomas DL. Global Elimination of Chronic Hepatitis. N Engl J Med. 2019;380(21):2041–50. doi: 10.1056/NEJMra1810477 ThomasDL Global Elimination of Chronic Hepatitis N Engl J Med 2019 380 21 2041 50 10.1056/NEJMra1810477 Open DOISearch in Google Scholar

7. Bertoletti A, Kennedy PT. The immune tolerant phase of chronic HBV infection: new perspectives on an old concept. Cell Mol Immunol. 2015;12(3):258–63. doi: 10.1038/cmi.2014.79 BertolettiA KennedyPT The immune tolerant phase of chronic HBV infection: new perspectives on an old concept Cell Mol Immunol 2015 12 3 258 63 10.1038/cmi.2014.79 Open DOISearch in Google Scholar

8. Khanam A, Chua JV, Kottilil S. Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression. Int J Mol Sci. 2021;22(11):5497. doi: 10.3390/ijms22115497 KhanamA ChuaJV KottililS Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression Int J Mol Sci 2021 22 11 5497 10.3390/ijms22115497 Open DOISearch in Google Scholar

9. Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560–99. doi: 10.1002/hep.29800 TerraultNA LokASF McMahonBJ ChangKM HwangJP JonasMM Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance Hepatology 2018 67 4 1560 99 10.1002/hep.29800 Open DOISearch in Google Scholar

10. Revill PA, Chisari FV, Block JM, Dandri M, Gehring AJ, Guo H, et al.; Members of the ICE-HBV Working Groups; ICE-HBV Stakeholders Group Chairs; ICE-HBV Senior Advisors; Zoulim F. A global scientific strategy to cure hepatitis B. Lancet Gastroenterol Hepatol. 2019;4(7):545–558. doi: 10.1016/S2468-1253(19)30119-0. Erratum in: Lancet Gastroenterol Hepatol. 2019 Jul;4(7):e7. doi: doi: 10.1016/S2468-1253(19)30151-7 RevillPA ChisariFV BlockJM DandriM GehringAJ GuoH Members of the ICE-HBV Working Groups; ICE-HBV Stakeholders Group Chairs; ICE-HBV Senior Advisors ZoulimF A global scientific strategy to cure hepatitis B Lancet Gastroenterol Hepatol 2019 4 7 545 558 10.1016/S2468-1253(19)30119-0 Erratum in: Lancet Gastroenterol Hepatol. 2019 Jul;4(7):e7. doi: doi: 10.1016/S2468-1253(19)30151-7 Open DOISearch in Google Scholar

11. Bhat SA, Kazim SN. HBV cccDNA-A culprit and stumbling block for the hepatitis B virus infection: its presence in hepatocytes perplexed the possible mission for a functional cure. ACS Omega. 2022;7(28):24066–81. doi: 10.1021/acsomega.2c02216 BhatSA KazimSN HBV cccDNA-A culprit and stumbling block for the hepatitis B virus infection: its presence in hepatocytes perplexed the possible mission for a functional cure ACS Omega 2022 7 28 24066 81 10.1021/acsomega.2c02216 Open DOISearch in Google Scholar

12. Revill PA, Penicaud C, Brechot C, Zoulim F. Meeting the challenge of eliminating chronic hepatitis B infection. Genes (Basel). 2019;10(4):260. doi: 10.3390/genes10040260 RevillPA PenicaudC BrechotC ZoulimF Meeting the challenge of eliminating chronic hepatitis B infection Genes (Basel) 2019 10 4 260 10.3390/genes10040260 Open DOISearch in Google Scholar

13. Lucifora J, Protzer U. Attacking hepatitis B virus cccDNA—the holy grail to hepatitis B cure. J Hepatol. 2016;64(1 Suppl):S41–S48. doi: 10.1016/j.jhep.2016.02.009 LuciforaJ ProtzerU Attacking hepatitis B virus cccDNA—the holy grail to hepatitis B cure J Hepatol 2016 64 1 Suppl S41 S48 10.1016/j.jhep.2016.02.009 Open DOISearch in Google Scholar

14. Indolfi G, Abdel-Hady M, Bansal S, Debray D, Smets F, Czubkowski P, et al. Management of hepatitis B virus infection and prevention of hepatitis B virus reactivation in children with acquired immunodeficiencies or undergoing immune suppressive, cytotoxic, or biological modifier therapies. J Pediatr Gastroenterol Nutr. 2020;70(4):527–538. doi: 10.1097/MPG.0000000000002628 IndolfiG Abdel-HadyM BansalS DebrayD SmetsF CzubkowskiP Management of hepatitis B virus infection and prevention of hepatitis B virus reactivation in children with acquired immunodeficiencies or undergoing immune suppressive, cytotoxic, or biological modifier therapies J Pediatr Gastroenterol Nutr 2020 70 4 527 538 10.1097/MPG.0000000000002628 Open DOISearch in Google Scholar

15. Hepatitis B. pp. 401-28. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, editors. Red Book: 2018–2021 Report of the Committee on Infectious Diseases. Committee on Infectious Diseases, American Academy of Pediatrics. 31st Edition. Itasca, IL: American Academy of Pediatrics, 2018:401–28. ISBN 978-1-61002-146-3. doi: 10.1542/9781610021470 (book doi). doi: 10.1542/9781610021470-part03-hepatitis_b (chapter doi) Hepatitis B 401 28 In: KimberlinDW BradyMT JacksonMA LongSS editors. Red Book: 2018–2021 Report of the Committee on Infectious Diseases. Committee on Infectious Diseases, American Academy of Pediatrics 31st Edition Itasca, IL American Academy of Pediatrics 2018 401 28 ISBN 978-1-61002-146-3. doi: 10.1542/9781610021470 (book doi). doi: 10.1542/9781610021470-part03-hepatitis_b (chapter doi) Open DOISearch in Google Scholar

16. El Agheb MO, Grange JD. Prévention de la transmission mèreenfant de l’hépatite B. (Prevention of mother to child transmission of hepatitis B). Pan Afr Med J. 2015;20:316. French. doi: 10.11604/pamj.2015.20.316.6193 El AghebMO GrangeJD Prévention de la transmission mèreenfant de l’hépatite B. (Prevention of mother to child transmission of hepatitis B) Pan Afr Med J 2015 20 316 French 10.11604/pamj.2015.20.316.6193 Open DOISearch in Google Scholar

17. European Association for the Study of the Liver; Collaborators: Lampertico P, Agarwal K, Berg T, Buti M, Janssen HLA, Papatheodoridis G, et al. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017 Aug;67(2):370–398. doi: 10.1016/j.jhep.2017.03.021 European Association for the Study of the Liver; Collaborators LamperticoP AgarwalK BergT ButiM JanssenHLA PapatheodoridisG EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection J Hepatol 2017 Aug 67 2 370 398 10.1016/j.jhep.2017.03.021 Open DOISearch in Google Scholar

18. Croagh CM, Lubel JS. Natural history of chronic hepatitis B: phases in a complex relationship. World J Gastroenterol. 2014;20(30):10395–404. doi: 10.3748/wjg.v20.i30.10395 CroaghCM LubelJS Natural history of chronic hepatitis B: phases in a complex relationship World J Gastroenterol 2014 20 30 10395 404 10.3748/wjg.v20.i30.10395 Open DOISearch in Google Scholar

19. Bortolotti F, Guido M, Bartolacci S, Cadrobbi P, Crivellaro C, Noventa F, et al. Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study. Hepatology. 2006;43(3):556–62. doi: 10.1002/hep.21077 BortolottiF GuidoM BartolacciS CadrobbiP CrivellaroC NoventaF Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study Hepatology 2006 43 3 556 62 10.1002/hep.21077 Open DOISearch in Google Scholar

20. Lu FT, Ni YH. Elimination of mother-to-infant transmission of hepatitis B virus: 35 years of experience. Pediatr Gastroenterol Hepatol Nutr. 2020;23(4):311–8. doi: 10.5223/pghn.2020.23.4.311 LuFT NiYH Elimination of mother-to-infant transmission of hepatitis B virus: 35 years of experience Pediatr Gastroenterol Hepatol Nutr 2020 23 4 311 8 10.5223/pghn.2020.23.4.311 Open DOISearch in Google Scholar

21. Komatsu H, Inui A, Fujisawa T. Pediatric hepatitis B treatment. Ann Transl Med. 2017;5(3):37. doi: 10.21037/atm.2016.11.52 KomatsuH InuiA FujisawaT Pediatric hepatitis B treatment Ann Transl Med 2017 5 3 37 10.21037/atm.2016.11.52 Open DOISearch in Google Scholar

22. Stinco M, Rubino C, Trapani S, Indolfi G. Treatment of hepatitis B virus infection in children and adolescents. World J Gastroenterol. 2021;27(36):6053–63. doi: 10.3748/wjg.v27.i36.6053 StincoM RubinoC TrapaniS IndolfiG Treatment of hepatitis B virus infection in children and adolescents World J Gastroenterol 2021 27 36 6053 63 10.3748/wjg.v27.i36.6053 Open DOISearch in Google Scholar

23. Mysore KR, Leung DH. Hepatitis B and C. Clin Liver Dis. 2018;22(4):703–22. doi: 10.1016/j.cld.2018.06.002 MysoreKR LeungDH Hepatitis B and C Clin Liver Dis 2018 22 4 703 22 10.1016/j.cld.2018.06.002 Open DOISearch in Google Scholar

24. WHO guidelines on hepatitis B and C testing. World Health Organization. Geneva: World Health Organization, 2017; 170 p. ISBN 978-92-4-154998-1. Available from: https://www.who.int/publications/i/item/9789241549981 WHO guidelines on hepatitis B and C testing World Health Organization Geneva World Health Organization 2017 170 p. ISBN 978-92-4-154998-1. Available from: https://www.who.int/publications/i/item/9789241549981 Search in Google Scholar

25. Costa JM, Telehin D, Munteanu M, Kobryn T, Ngo Y, Thibault V, et al. HCV-GenoFibrotest: a combination of viral, liver and genomic (IL28b, ITPA, UGT1A1) biomarkers for predicting treatment response in patients with chronic hepatitis C. Clin Res Hepatol Gastroenterol. 2011;35(3):204–13. doi: 10.1016/j.clinre.2011.01.005 CostaJM TelehinD MunteanuM KobrynT NgoY ThibaultV HCV-GenoFibrotest: a combination of viral, liver and genomic (IL28b, ITPA, UGT1A1) biomarkers for predicting treatment response in patients with chronic hepatitis C Clin Res Hepatol Gastroenterol 2011 35 3 204 13 10.1016/j.clinre.2011.01.005 Open DOISearch in Google Scholar

26. Mărginean CO, Meliț LE, Săsăran MO. Elastography—a bona fide non-invasive method for assessing non-alcoholic fatty liver disease in children. Applied Sciences. 2021;11(7):3240. doi: 10.3390/app11073240 MărgineanCO MelițLE SăsăranMO Elastography—a bona fide non-invasive method for assessing non-alcoholic fatty liver disease in children Applied Sciences 2021 11 7 3240 10.3390/app11073240 Open DOISearch in Google Scholar

27. Rodriguez-Baez N, Murray KF, Kleiner DE, Ling SC, Rosenthal P, Carlin K, et al. Hepatic histology in treatment-naïve children with chronic hepatitis B infection living in the United States and Canada. J Pediatr Gastroenterol Nutr. 2020;71(1): 99–105. doi: 10.1097/MPG.0000000000002712 Rodriguez-BaezN MurrayKF KleinerDE LingSC RosenthalP CarlinK Hepatic histology in treatment-naïve children with chronic hepatitis B infection living in the United States and Canada J Pediatr Gastroenterol Nutr 2020 71 1 99 105 10.1097/MPG.0000000000002712 Open DOISearch in Google Scholar

28. Indolfi G, Easterbrook P, Dusheiko G, Siberry G, Chang MH, Thorne C, et al. Hepatitis B virus infection in children and adolescents. Lancet Gastroenterol Hepatol. 2019;4(6):466–76. doi: 10.1016/S2468-1253(19)30042-1. Erratum in: Lancet Gastroenterol Hepatol. 2020;5(5):e4. doi: 10.1016/S2468-1253(20)30092-3 IndolfiG EasterbrookP DusheikoG SiberryG ChangMH ThorneC Hepatitis B virus infection in children and adolescents Lancet Gastroenterol Hepatol 2019 4 6 466 76 10.1016/S2468-1253(19)30042-1 Erratum in: Lancet Gastroenterol Hepatol. 2020;5(5):e4 10.1016/S2468-1253(20)30092-3 Open DOISearch in Google Scholar

29. Wong WWL, Pechivanoglou P, Wong J, Bielecki JM, Haines A, Erman A, et al. Antiviral treatment for treatment-naïve chronic hepatitis B: systematic review and network meta-analysis of randomized controlled trials. Syst Rev. 2019;8(1):207. doi: 10.1186/s13643-019-1126-1 WongWWL PechivanoglouP WongJ BieleckiJM HainesA ErmanA Antiviral treatment for treatment-naïve chronic hepatitis B: systematic review and network meta-analysis of randomized controlled trials Syst Rev 2019 8 1 207 10.1186/s13643-019-1126-1 Open DOISearch in Google Scholar

30. Wei S, Hu M, Chen H, Xie Q, Wang P, Li H, et al. Effectiveness of antiviral treatment in HBeAg-negative chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase: a retrospective study. BMC Gastroenterol. 2022;22(1):387. doi: 10.1186/s12876-022-02471-y WeiS HuM ChenH XieQ WangP LiH Effectiveness of antiviral treatment in HBeAg-negative chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase: a retrospective study BMC Gastroenterol 2022 22 1 387 10.1186/s12876-022-02471-y Open DOISearch in Google Scholar

31. Li M, Sun F, Bi X, Lin Y, Yang L, Lu Y, et al. Consolidation treatment needed for sustained HBsAg-negative response induced by interferon-alpha in HBeAg positive chronic hepatitis B patients. Virol Sin. 2022;37(3):390–7. doi: 10.1016/j.virs.2022.03.001 LiM SunF BiX LinY YangL LuY Consolidation treatment needed for sustained HBsAg-negative response induced by interferon-alpha in HBeAg positive chronic hepatitis B patients Virol Sin 2022 37 3 390 7 10.1016/j.virs.2022.03.001 Open DOISearch in Google Scholar

32. Pan J, Wang H, Yao T, Liao X, Cheng H, Liangpunsakul S, et al. Clinical predictors of functional cure in children 1–6 years-old with chronic hepatitis B. J Clin Transl Hepatol. 2022;10(3):405–11. doi: 10.14218/JCTH.2021.00142 PanJ WangH YaoT LiaoX ChengH LiangpunsakulS Clinical predictors of functional cure in children 1–6 years-old with chronic hepatitis B J Clin Transl Hepatol 2022 10 3 405 11 10.14218/JCTH.2021.00142 Open DOISearch in Google Scholar

33. Zhong YW, Shi YM, Chu F, Liu J, Shi C, Xu JJ, et al. Prediction for HBsAg seroconversion in children with chronic hepatitis B. BMC Infect Dis. 2021;21(1):1211. doi: 10.1186/s12879-021-06883-1 ZhongYW ShiYM ChuF LiuJ ShiC XuJJ Prediction for HBsAg seroconversion in children with chronic hepatitis B BMC Infect Dis 2021 21 1 1211 10.1186/s12879-021-06883-1 Open DOISearch in Google Scholar

34. Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10(1):1–98. doi: 10.1007/s12072-015-9675-4. SarinSK KumarM LauGK AbbasZ ChanHL ChenCJ Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update Hepatol Int 2016 10 1 1 98 10.1007/s12072-015-9675-4 Open DOISearch in Google Scholar

35. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. World Health Organization; Global HIV, Hepatitis and Sexually Transmitted Infections Programmes. Geneva, Switzerland : WHO, March 2015; XXX, 134 p. ISBN 978 92 4 154905 9. Available from: https://www.who.int/publications/i/item/9789241549059 Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection World Health Organization; Global HIV, Hepatitis and Sexually Transmitted Infections Programmes Geneva, Switzerland WHO March 2015 XXX, 134 p. ISBN 978 92 4 154905 9. Available from: https://www.who.int/publications/i/item/9789241549059 Search in Google Scholar

36. NICE National Institute for Health and Care Excellence. Hepatitis B (chronic): diagnosis and management : clinical guideline. CG165. London, Manchester, UK: NICE, published June 2013, corrected January 2014, last updated October 2017; 36 p. Published 26 June 2013. Las Updated 20 October 2017. ISBN 978-1-4731-4724-9. Available from: https://www.nice.org.uk/guidance/cg165 NICE National Institute for Health and Care Excellence Hepatitis B (chronic): diagnosis and management : clinical guideline. CG165 London, Manchester, UK NICE published June 2013, corrected January 2014, last updated October 2017; 36 p. Published 26 June 2013. Las Updated 20 October 2017. ISBN 978-1-4731-4724-9. Available from: https://www.nice.org.uk/guidance/cg165 Search in Google Scholar

37. Sokal EM, Paganelli M, Wirth S, Socha P, Vajro P, Lacaille F, Kelly D, Mieli-Vergani G; European Society of Pediatric Gastroenterology, Hepatology and Nutrition. Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition. J Hepatol. 2013 Oct;59(4):814–29. doi: 10.1016/j.jhep.2013.05.016 SokalEM PaganelliM WirthS SochaP VajroP LacailleF KellyD Mieli-VerganiG European Society of Pediatric Gastroenterology, Hepatology and Nutrition Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition J Hepatol 2013 Oct 59 4 814 29 10.1016/j.jhep.2013.05.016 Open DOISearch in Google Scholar